The North American Menopause Society has recently endorsed a flexible approach to the use of HRT that takes into account the individual patient’s needs, the type and timing of the therapy.
The North American Menopause Society has recently endorsed a flexible approach to the use of HRT. This takes into account the individual patient’s needs, the type and timing of the therapy.
First patient dosed in trial evaluating fezolinetant for VMS in breast cancer patients
August 28th 2024Astellas Pharma has announced the first dose administration of fezolinetant to manage moderate to severe vasomotor symptoms in breast cancer patients using adjuvant endocrine therapy.
Read More
Higher multimorbidity risk reported from reduced reproductive lifespan
August 12th 2024A recent study found that women with a shorter reproductive lifespan had increased odds of multimorbidity compared to those with a longer reproductive lifespan, indicating a need to assess reproductive factors to determine high-risk patients.
Read More